发明名称 |
DUPA-INDENOISOQUINOLINE CONJUGATES |
摘要 |
A targeting ligand-cytotoxic drug conjugate, for example, a DUPA-Indenoisoquinoline conjugate, is useful for treating cancers, e.g., prostate cancer. |
申请公布号 |
US2016367685(A1) |
申请公布日期 |
2016.12.22 |
申请号 |
US201415035157 |
申请日期 |
2014.11.05 |
申请人 |
PURDUE RESEARCH FOUNDATION |
发明人 |
Cushman Mark S.;Low Phillip S.;Nguyen Trung X. |
分类号 |
A61K47/48;A61K31/473 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
1. A DUPA-Indenoisoquinoline conjugate represented by formula (IB)
DUPA-Linker-RS-Indenoisoquinoline (IB)wherein
DUPA is a modified or unmodified 2-[3-(1,3-dicarboxypropyl)-ureido]pentanedioic acid; Linker is a bond, a substituted or unsubstituted alkyl, a peptide, or a peptidoglycan; Indenoisoquinoline is a substituted or unsubstituted indenoisoquinoline; and RS is a release segment capable of releasing Indenoisoquinoline within the desired cells,wherein said release segment is a carbonate segment, a carbamate segment, or an acylhydrazone segment. |
地址 |
West Lafayette IN US |